INTRODUCTION AND OBJECTIVES: Detrusor underactivity is
an important yet still under-research issue. The treatment outcome in patients with detrusor underactivity (DU) is usually unfavorable and no better compared to untreated patients. Therefore, we aim to identify the predictive factors of satisfactory treatment in male patients with detrusor underactivity.
METHODS: We retrospectively reviewed 86 cases of men with video-urodynamic proven detrusor underactivity from 2000 to 2015. DU was defined as low voiding pressure, low flow rate, post void residual (PVR)>300mL and a low voiding efficiency (VE) < 33% in this study. VE > 50% after treatment was considered satisfactory outcome. Patient's demographics and urodynamic parameters include first sensation of filling (FSF), full sensation of filling (FS), urgency sensation (US), compliance at capacity, maximal flow rate (Qmax), detrusor voiding pressure (Pdet), voided volume, cystometric bladder capacity (CBC) and PVR were compared between the satisfactory group and unsatisfactory group. Various treatment options including transurethral resection of prostate (TURP), transurethral incision of prostate (TUIP) and medication (include botulinum toxin injection) were performed according to clinical and video-urodynamics findings.
RESULTS: After a mean follow up of 31 months, 63 patients had satisfactory outcome. Satisfactory group has significantly higher detrusor pressure and compliance at capacity than unsatisfactory group. There was significant improvement in FSF, FD, US, Pdet, Qmax, voided volume, PVR and CBC after treatment in satisfactory group meanwhile in unsatisfactory group there were only significant changes in US, PVR and CBC.
CONCLUSIONS: A higher detrusor pressure and compliance at capacity at baseline were predictive of satisfactory treatment outcomes in male patient with detrusor underactivity. INTRODUCTION AND OBJECTIVES: Symptoms score are integral tools in urology allowing for assessment of severity of symptoms, progression of symptoms and efficacy of therapy, though they inherently depend on literacy and language interpretation. To extend the concept of the male Visual Prostate Symptom Score (VPSS), we proposed a female specific visual score that would circumvent literacy comprehension and provide validated symptom information on frequency, nocturia, urgency, stress urinary incontinence (SUI), dysuria and quality of life (QoL). Objectives: Develop the Visual Urinary Symptom Score for Women (VUSS) score and content validity by: (1) evaluate construct validity through patient understanding of each pictogram (2) comparing VUSS pictograms responses to the Urinary Distress Inventory (UDI-6) and the American Urological Associated Symptom Inventory (AUA-SI) (3) obtain patient input to enhance information capture.
Source of Funding: None
METHODS: English speaking women were recruited by posters in the Greater Vancouver Area. They completed the VUSS, the UDI-6 and the AUA-SI independently, described their interpretations of each pictogram and provided feedback for each image to improve comprehension. Statistical analysis: Students t, Fishers exact, and Spearmans correlation tests.
RESULTS: 300 scores in N¼100 were collected (mean age 46, range 21-91); 25 had grade 8-12 high school education; 75 with postsecondary education (mean 4.2 years, range of 0 years to 8 years). All surveys were completed independently. VUSS Q1 and Q2, indicating daytime frequency and nocturia, had the best inherent recognition of concept with 97% correct interpretation. QoL had the poorest inherent recognition of concept with 72% correct interpretation. VUSS Q5, indicating dysuria, was thought by the participants to be the clearest. VUSS e748 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 and UDI-6 totals had 0.878 correlation, while VUSS AUA-SI had 0.72 correlation. CONCLUSIONS: VUSS content correlated well with UDI-6 total scores. Comprehension would benefit from increasing contrast details in pictograms. Further development can add to the ability to measure womens LUTS on a global scale to reduce language and literacy barriers to urologic history taking. Next steps will incorporate changes from this validation and testing in a low resource environment.
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PREDICTORS OF URINARY RETENTION IN MALE PATIENTS RECEIVING INTRADETRUSOR BOTULINUM TOXIN INJECTIONS
Daniel Hoffman*, New York, NY; Ekene Enemchukwu, Stanford, CA; Victor Nitti, New York, NY INTRODUCTION AND OBJECTIVES: Intradetrusor onabotuli-numtoxinA (BTX-A) BTX-A injections are an established third-line therapy for the treatment of overactive bladder (OAB). Incomplete bladder emptying requiring clean intermittent catheterization (CIC) is a side effect that limits patient acceptability of BTX-A. There are studies that have evaluated risk factors that predispose to need for CIC, but few have looked at parameters that may confer protection against CIC. Herein we present an initial report of a cohort of men who have undergone prostatectomy and subsequent BTX-A for OAB.
METHODS: A retrospective chart review of patients receiving BTX-A for OAB refractory to antimuscarinics and/or beta 3agonists from 2010 to 2016 was performed. We sought to identify predictors of elevated post-void residual (PVR) leading to CIC in patients not expected to CIC post treatment. A subset of men who had undergone prostatectomy for benign or malignant disease (open or robotic radical prostatectomy (RP), or transurethral procedure (TUR) for BPH were identified. All men received 100 units of onabotulinumtoxinA under local anesthesia by flexible cystoscope. PVR was measured 2 weeks after the procedure. We generally recommend CIC for PVR 200 -349 ml with symptoms or greater than 350mL with or without symptoms. Clinical variables were correlated with PVR/CIC at their subsequent evaluations. Patients with neurogenic DO and those performing CIC prior to BTX-A injection were excluded.
RESULTS: 71 men were identified. Of these, 45 (63.4%) had surgical interventions on their prostate; 23 (32.4 %) had open or robotic RP and 22 (31 %) had a TUR for BPH. The overall rate of CIC was 12.7%. Three (13.6%) men in the TUR group required CIC vs. 6 (23%) who had an intact prostate No men in the RP group required CIC. The median post BTX-A PVR in the RP group was 44 ml when compared to 104 in the TUR group and 197ml in the group with intact prostates. (Table) CONCLUSIONS: The rate of CIC in men receiving BTX-A for OAB in our cohort was 12.7%, somewhat higher than is seen in women. Prior RP appears to have a protective effect against CIC (p¼0.02) and elevation of PVR (p¼0.001). No man required CIC after RP. Prior TUR does not confer protection against CIC (p¼0.5) but may protect against elevation of PVR (p¼.03). A proposed mechanism for better emptying after surgery may be the ability to Valsalva void. METHODS: Clinical and pathological data of 364 patients who underwent radical prostatectomy in Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine between February 2013 and February 2015 were prospectively collected, including 7 lifestyle and comorbidity factors (age, BMI, smoking, etc.), 11 preoperative clinical factors (prostate volume, biopsy approaches, preoperative lower urinary symptoms, etc.), surgeon and surgical method, 4 postoperative clinical factors (complications, postoperative PSA, etc.) and 9 pathological factors (pT, pN, Gleason score, etc.). The incidence, severity and recovery of PPI was followed up by phone call and email. Logistic regression analysis
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